Application | Comment | Organism |
---|---|---|
medicine | muscle enzyme SENP2 can be a therapeutic target for the treatment of obesity-linked metabolic disorders | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
C2C12 cell | - |
Mus musculus | - |
myotube | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
SENP2 | - |
Mus musculus |
small ubiquitin-like modifier-specific protease | - |
Mus musculus |
SUMO-specific protease | - |
Mus musculus |
Organism | Comment | Expression |
---|---|---|
Mus musculus | in C2C12 myotubes, treatment with saturated fatty acids, like palmitate, leads to nuclear factor-kappaB-mediated increase in the expression of SENP2 | up |
General Information | Comment | Organism |
---|---|---|
physiological function | nuclear factor-kappaB-mediated increase in the expression of SENP2 promotes the recruitment of peroxisome proliferator-activated receptors PPARdelta and PPARgamma, through deSUMOylation of PPARs, to the promoters of the genes involved in fatty acid oxidation, such as carnitine-palmitoyl transferase-1 and long-chain acyl-CoA synthetase 1. Enzyme overexpression substantially increases fatty acid oxidation in C2C12 myotubes | Mus musculus |